C1GALT1 and breast cancer: Similarly, both in vivo and in vitro studies demonstrated that hepatocellular carcinoma cells lacking C1GalT1 exhibited reduced Ki‐67 staining compared to wild‐type [36], and breast cancer tissues in C1GalT1‐deficient mice showed fewer Ki67‐positive cells [48].